Next-generation RELiZORB technology expands device utility to support more patients including many living with SBS and other rare diseases. WALTHAM, Mass., Dec. 21, 2023 /PRNewswire/ -- Alcresta ...
WALTHAM, Mass., Nov. 3, 2025 /PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced that ...
WALTHAM, Mass., Aug. 31, 2023 /PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback